APA引文

Byron, S. A., Loch, D. C., Wellens, C. L., Wortmann, A., Wu, J., Wang, J., . . . Pollock, P. M. (2012). Sensitivity to the MEK inhibitor E6201 in melanoma cells is associated with mutant BRAF and wildtype PTEN status. BioMed Central.

Citação norma Chicago

Byron, Sara A., David C. Loch, Candice L. Wellens, Andreas Wortmann, Jiayi Wu, John Wang, Kenichi Nomoto, and Pamela M. Pollock. Sensitivity to the MEK Inhibitor E6201 in Melanoma Cells Is Associated With Mutant BRAF and Wildtype PTEN Status. BioMed Central, 2012.

MLA引文

Byron, Sara A., et al. Sensitivity to the MEK Inhibitor E6201 in Melanoma Cells Is Associated With Mutant BRAF and Wildtype PTEN Status. BioMed Central, 2012.